At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 29 enrolled
Drug / intervention
Lidocaine +1 moredrug
Likely dose
Lidocaine 3 mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Long Term Outcome After Serial Lidocaine Infusion in Peripheral Neuropathic Pain : A Pilot Study
In Brief
A Phase 3 clinical trial evaluating Lidocaine and Placebo for Peripheral Neuropathy. Completed, enrolled 29 participants across 1 site.
Detailed Summary
The purpose of this study to evaluated Long term outcome after serial Lidocaine infusion when compared with placebo in peripheral neuropathic pain patients in acute stage (less than 6 months) at 3 months after first time of infusion
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPeripheral Neuropathy
CountriesThailand
Collaborators--
Timeline
Phase 3CompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartAug 2014
First PostedAug 2014
Primary CompletionDec 2017
Study CompletionFeb 2018
TodayJul 2026
First PostedAug 15, 2014
Enrollment StartAug 1, 2014
Primary CompletionDec 29, 2017
Study CompletionFeb 1, 2018
TodayJul 2, 2026
Enrollment to primary: 3.4 yearsPosted 11.9 years ago
Interventions
Lidocainedrug
Lidocaine 3 mg/kg dilute in Normal Saline to 50 ml intravenous infusion in 1 hour
Placebodrug